(Q40938710)

25 September 2017

1 reference

title

Thrombosis and the pharmacology of antithrombotic agents (English)

1 reference

25 September 2017

1 reference

S T Haines

1

1 reference

25 September 2017

H I Bussey

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

Annals of Pharmacotherapy

25 September 2017

published in

1 reference

25 September 2017

volume

29

1 reference

25 September 2017

issue

9

1 reference

25 September 2017

page(s)

892-905

1 reference

Molecular and cellular biology of blood coagulation

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Overview of hemostasis and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The physiological aspects of fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Integrins: a family of cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The coagulation cascade: initiation, maintenance, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Activation of factor VII bound to tissue factor: a key early step in the tissue factor pathway of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Fibrin: structure and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Antithrombin: the principal inhibitor of thrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Regulation of thrombin activity by antithrombin and heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Interaction of plasminogen activators and inhibitors with plasminogen and fibrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Inhibitors of the Fibrinolytic Enzyme System

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Overview of venous thrombogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Resistance to activated protein C as a basis for venous thrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Hypercoagulable states: molecular genetics to clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The hemostatic system and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Fibrin as a factor in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

A modern view of atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Development of GPIIb/IIIa antagonists as antithrombotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The warfarin-cimetidine interaction: stereochemical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

21 January 2018

Oral anticoagulant drugs

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Structure and activity of heparin and its fragments: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Pharmacodynamics, clinical indications, and adverse effects of heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Low Molecular Weight Heparins: An Emerging New Class of Glycosaminoglycan Antithrombotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Comparative human pharmacology of low molecular weight heparins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

More to "heparin" than anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Enoxaparin: the low-molecular-weight heparin for prevention of postoperative thromboembolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Hirudins: antithrombin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

The development of hirudin as an antithrombotic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Specific thrombin inhibitors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Hirudin: clinical potential of a thrombin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

Pharmacokinetics of Hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809502900912

10.1177/106002809502900912

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference